Macrophages Inhibit Insulin Signalling in Adipocytes: Role of Inducible Nitric Oxide Synthase and Nitric Oxide

Canadian Journal of Diabetes

Volumn 39, Issue 1, 2015, Pages 36-43

  Fite, Alemu ^a   Abou Samra, Abdul Badi ^a,b   Seyoum, Berhane ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

Akt AS160; Glucose consumption; Inflammation; Insulin resistance; Macrophage infiltration

Indexed keywords

ADIPONECTIN; BACTERIUM LIPOPOLYSACCHARIDE; CELL PROTEIN; GLUCOSE TRANSPORTER 4; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; LINSIDOMINE; MESSENGER RNA; N(G) METHYLARGININE; NITRIC OXIDE; PROTEIN AS160; PROTEIN KINASE B; UNCLASSIFIED DRUG; GLUCOSE; GLUCOSE TRANSPORTER 1; NOS2 PROTEIN, MOUSE; ONCOPROTEIN; SLC2A1 PROTEIN, MOUSE;

3T3 CELL LINE; ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DENSITY; CELL INTERACTION; COCULTURE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORT; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN SIGNALLING; MACROPHAGE; MACROPHAGE ACTIVATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL LINE; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL LINE; COCULTURE TECHNIQUES; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; INSULIN; INSULIN RESISTANCE; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84921286131     PISSN: 14992671     EISSN: 23523840     Source Type: Journal    
DOI: 10.1016/j.jcjd.2014.02.023     Document Type: Article

References (30)

1. Blasi E., Mathieson B.J., Varesio L. Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus. Nature 1985, 318:667-670.
2. Ortega Martinez de Victoria E., Xu X., Koska J., et al. Macrophage content in subcutaneous adipose tissue. Diabetes 2009, 58:385-393.
3. Furuhashi M., Fucho R., Gorgun C.Z., et al. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. JClin Invest 2008, 118:2640-2650.
4. Suganami T., Ogawa Y. Adipose tissue macrophages: Their role in adipose tissue remodeling. JLeukoc Biol 2010, 88:33-39.
5. Sun K., Kusminski C.M., Scherer P.E. Adipose tissue remodeling and obesity. JClin Invest 2011, 121:2094-2101.
6. Nielsen S., Guo Z., Johnson C.M., et al. Splanchnic lipolysis in human obesity. JClin Invest 2004, 113:1582-1588.
7. Perreault M., Marette A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 2001, 7:1138-1143.
8. - induced tyrosine nitration of IRS-1 in skeletal muscle. PLoS ONE 2010, 5:e15912.
9. Bedard S., Marcotte B., Marette A. Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase. Biochem J 1997, 325:487-493.
10. Charbonneau A., Marette A. Inducible nitric oxide synthase induction underlies lipid-induced hepatic insulin resistance in mice: Potential role of tyrosine nitration of insulin signaling proteins. Diabetes 2010, 59:861-871.
11. Tanaka T., Nakatani K., Morioka K., et al. Nitric oxide stimulates glucose transport through insulin-independent GLUT4 translocation in 3T3-L1 adipocytes. Eur JEndocrinol 2003, 149:61-67.
12. Balon T.W., Nadler J.L. Evidence that nitric oxide increases glucose transport in skeletal muscle. JAppl Physiol 1997, 82:359-363.
13. Krause M., Rodrigues-Krause J., O'Hagan C., et al. Differential nitric oxide levels in the blood and skeletal muscle of type 2 diabetic subjects may be consequence of adiposity: A preliminary study. Metabolism 2012, 61:1528-1537.
14. Seyoum B., Fite A., Abou-Samra A.B. Effects of 3T3 adipocytes on interleukin-6 expression and insulin signaling in L6 skeletal muscle cells. Biochem Biophys Res Commun 2011, 410:13-18.
15. Green H., Kehinde O. An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion. Cell 1975, 5:19-27.
16. Rosen E.D., Walkey C.J., Puigserver P., et al. Transcriptional regulation of adipogenesis. Genes Dev 2000, 14:1293-1307.
17. Berghaus L.J., Moore J.N., Hurley D.J., et al. Innate immune responses of primary murine macrophage-lineage cells and RAW 264.7 cells to ligands of Toll-like receptors 2, 3, and 4. Comp Immunol Microbiol Infect Dis 2010, 33:443-454.
18. Green H., Meuth M. An established pre-adipose cell line and its differentiation in culture. Cell 1974, 3:127-133.
19. Blake D.A., McLean N.V. Acolorimetric assay for the measurement of D-glucose consumption by cultured cells. Anal Biochem 1989, 177:156-160.
20. Mizutani A., Maki H., Torii Y., et al. Ascorbate-dependent enhancement of nitric oxide formation in activated macrophages. Nitric Oxide 1998, 2:235-241.
21. Shirai K., Okada T., Konishi K., et al. Bicarbonate plays a critical role in the generation of cytotoxicity during SIN-1 decomposition in culture medium. Oxid Med Cell Longev 2012, 2012:15.
22. Suganami T., Nishida J., Ogawa Y. Aparacrine loop between adipocytes and macrophages aggravates inflammatory changes: Role of free fatty acids and tumor necrosis factor α. Arterioscler Thromb Vasc Biol 2005, 25:2062-2068.
23. Sano H., Kane S., Sano E., et al. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. JBiol Chem 2003, 278:14599-14602.
24. Thong F.S.L., Dugani C.B., Klip A. Turning signals on and off: GLUT4 traffic in the insulin-signaling highway. Physiology 2005, 20:271-284.
25. Higaki Y., Hirshman M.F., Fujii N., et al. Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes 2001, 50:241-247.
26. McGrowdera D., Ragoobirsingh D., Brown P. Modulation of glucose uptake in adipose tissue by nitric oxide-generating compounds. JBiosci 2006, 31:347-354.
27. Forrester M.T., Stamler J.S. Aclassification scheme for redox-based modifications of proteins. Am J Respir Cell Mol Biol 2007, 36:135-137.
28. Szabo C., Ischiropoulos H., Radi R. Peroxynitrite: Biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 2007, 6:662-680.
29. Sugita H., Fujimoto M., Yasukawa T., et al. Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells. JBiol Chem 2005, 280:14203-14211.
30. Yasukawa T., Tokunaga E., Ota H., et al. S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. JBiol Chem 2005, 280:7511-7518.